ro7171009

mAbexperimental

Clinical trial activity

3 trials · 2 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0

Earliest trial started Sep 21, 2017 (NCT03295877)

Timeline

2010s

  1. Jan 1, 2017

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2019

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Multi-specific
No

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT04607148Phase 2Nov 16, 2020Genentech, Roche
NCT03972709Phase 2Jun 3, 2019Genentech, Roche
NCT03295877Phase 1Sep 21, 2017Genentech, Roche
Showing 3 of 3 trials
Page 1 / 1

Organizations

Research & Development (2)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
GenentechFor profit3322017
RocheFor profit3022017
2 organizations
Page 1 / 1